Ironwood Pharmaceuticals | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
Almirall EUR 53.03M 68.53M 2024-06
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amarin USD -25168000 24.64M 2024-09
Ardelyx USD 8.12M 5.89M 2024-12
Astellas Pharma JPY -116191000000 159.24B 2024-12
AstraZeneca USD 2.04B 731M 2024-12
Charles River Laboratories USD -167687000 285.09M 2024-12
Exact Sciences USD -876351000 836.95M 2024-12
Halozyme Therapeutics USD 175.5M 12.3M 2024-12
Incyte USD 301.51M 155.43M 2024-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
MacroGenics USD 54.19M 112.37M 2024-09
Moderna USD -1246000000 1.18B 2024-12
Myriad Genetics USD -39000000 19M 2024-12
Pacira USD 24.7M 164.23M 2024-12
PTC Therapeutics USD -62489000 7.98M 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Takeda JPY 66.94B 117.3B 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12



Ironwood Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.